Format

Send to

Choose Destination
Adv Drug Deliv Rev. 2017 Jun 1;115:1-2. doi: 10.1016/j.addr.2017.08.007.

Preface: Nanoformulations for combination or cascade anticancer therapy.

Author information

1
School of Pharmaceutical Science, Peking University Health Science Center, 100191, Xueyuan Road 38, Beijing, P.R. China.
2
Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7571, USA.
PMID:
28887913
DOI:
10.1016/j.addr.2017.08.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center